Institute of BioMedical Research Corp. (MRES)
0.0030
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Institute of BioMedical Research Profit Margin (Quarterly) : -206.0% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -206.0% |
| March 31, 2026 | |
| December 31, 2025 | |
| September 30, 2025 | |
| June 30, 2025 | -393.9% |
| March 31, 2025 | -1.56K% |
| December 31, 2024 | |
| September 30, 2024 | -2.19K% |
| June 30, 2024 | -3.08K% |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | -6.17K% |
| June 30, 2023 | -3.18K% |
| March 31, 2023 | |
| December 31, 2022 | -2.44K% |
| September 30, 2022 | -2.48K% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 40.19% |
| March 31, 2015 | 41.86% |
| December 31, 2014 | 40.01% |
| September 30, 2014 | 40.08% |
| June 30, 2014 | 37.13% |
| March 31, 2014 | 60.24% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | -- |
| Cavitation Technologies, Inc. | -7.30K% |
| Clene, Inc. | -14.92K% |
| Bon Natural Life Ltd. | -- |
| Biohaven Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -273.5% |
| Return on Assets | -176.3% |
| Return on Invested Capital | -273.5% |
| Operating Margin (Quarterly) | -177.2% |
| Return on Net Operating Assets | -179.8% |